"The 12 hour AEP was very helpful and the instructor did a great job presenting the class"
Maryland Addiction Overview
Maryland has confronted one of the nation's most severe substance use crises over the past decade, with Baltimore City historically carrying one of the highest overdose burdens of any major American city. While synthetic opioids like fentanyl dominate fatal overdose statistics, alcohol remains a leading driver of treatment admissions across the state. According to the Substance Abuse and Mental Health Services Administration, alcohol use disorder affects hundreds of thousands of Marylanders, making it a persistent public health challenge that often intersects with opioid and stimulant use.
The state's overdose death toll has declined from its pandemic-era peak as harm reduction strategies and expanded treatment access have taken hold. Fentanyl and other synthetic opioids remain the primary fatal driver, but cocaine involvement in overdose deaths has increased substantially, often in combination with fentanyl. This polysubstance pattern complicates treatment because many individuals seeking help for alcohol dependence also have histories with other substances. Data from the Centers for Disease Control and Prevention shows that Maryland's overdose mortality rate consistently exceeds the national average, underscoring the urgency of accessible treatment across all substance categories.
Alcohol use disorder in Maryland disproportionately affects working-age adults between 25 and 54, though concerning trends have emerged among young adults and older populations as well. The state's diverse geography creates distinct regional patterns. Urban centers like Baltimore see high volumes of individuals with co-occurring opioid and alcohol use disorders, while suburban communities in Montgomery and Prince George's Counties more frequently present with alcohol as the primary substance of concern. Rural areas along the Eastern Shore and in Western Maryland face unique challenges, including limited treatment access and economic stressors that contribute to higher rates of heavy drinking.
Binge drinking and heavy alcohol use remain prevalent across demographic groups, with the National Institute on Alcohol Abuse and Alcoholism noting that approximately one in four adults nationwide engage in binge drinking patterns. In Maryland, these patterns translate to significant healthcare utilization, including emergency department visits for alcohol-related injuries, hospitalizations for liver disease, and long-term disability from alcohol-associated neurological damage. The economic cost extends to lost productivity, family disruption, and involvement with the criminal justice system.
Co-occurring mental health conditions complicate alcohol treatment for many Marylanders. Anxiety disorders, depression, and trauma-related conditions frequently accompany alcohol dependence, requiring integrated treatment approaches that address both the substance use and the underlying psychological factors. Maryland's treatment system has increasingly recognized the need for dual-diagnosis care, though gaps remain, particularly in underserved areas where specialized providers are scarce.
Treatment Landscape in Maryland
Maryland operates a robust treatment infrastructure with 1,448 SAMHSA-licensed treatment facilities distributed across the state. This facility count reflects the state's substantial investment in behavioral health services, though geographic distribution favors population centers. The Baltimore metropolitan area, home to roughly half the state's population, contains the highest concentration of programs, followed by the Washington DC suburbs in Montgomery and Prince George's Counties. The Interstate-95 corridor from Baltimore through the Capital Region offers the most accessible treatment options for residents in those areas.
Maryland distinguishes itself through an accreditation-based licensure system under COMAR 10.63 that requires most substance use disorder programs to obtain national accreditation from The Joint Commission, CARF International, or the Council on Accreditation before the state will issue a license. This requirement establishes baseline quality standards across the treatment system, though it can create barriers for smaller programs seeking to enter the market. The system encompasses the full continuum of care: outpatient counseling, intensive outpatient programs meeting several times weekly, partial hospitalization providing structured daytime treatment, residential programs at multiple ASAM levels from 3.1 clinically managed low-intensity to 3.7 medically monitored high-intensity, and medically supervised detoxification for individuals requiring withdrawal management.
Medication-assisted treatment has become increasingly available throughout Maryland as the opioid crisis prompted expanded access to evidence-based pharmacotherapies. All three FDA-approved medications for opioid use disorder are available, with methadone dispensed through licensed opioid treatment programs and buprenorphine prescribed in both specialty clinics and office-based settings. For alcohol use disorder specifically, naltrexone, acamprosate, and disulfiram are available through outpatient providers and many residential programs. Maryland Medicaid covers these medications, and the public behavioral health system funds access for eligible individuals. According to the National Institute on Drug Abuse, combining medication with behavioral therapies produces the best outcomes for most individuals with substance use disorders.
Rural and underserved regions face significant treatment gaps despite the statewide facility count. Western Maryland counties like Allegany and Garrett have limited residential options and fewer specialized providers, requiring many residents to travel considerable distances or rely on regional referral networks. The Eastern Shore presents similar challenges, with treatment capacity concentrated in the Salisbury area while other communities have minimal local options. Telehealth has emerged as a partial solution, allowing some individuals in remote areas to access counseling and medication management without extensive travel. Still, detoxification and residential care necessarily require physical facilities, leaving geographic barriers in place for those needing higher levels of care.
The state's Certificate of Need requirement for residential inpatient behavioral health beds aims to ensure efficient resource allocation but can also constrain capacity expansion in areas with growing demand. Public and nonprofit treatment providers serve a substantial portion of individuals seeking care, particularly those covered by Medicaid or lacking insurance entirely. Private treatment centers, including several facilities focused specifically on alcohol rehabilitation, offer additional options for individuals with commercial insurance or private payment capacity. The mix of public and private providers creates pathways into treatment across economic circumstances, though navigating the system often requires assistance from care coordinators or referral specialists.